<?xml version="1.0" encoding="UTF-8"?>
<p id="para0013">Scientists around the world are looking for drugs that could be beneficial in COVID-19 treatment. Many drugs have been studied that are listed in 
 <xref rid="tbl0001" ref-type="table">Table 1</xref> with the usual dosage ranges in adults and pediatrics. The latest Guidelines for the Prevention, Diagnosis, and Treatment of Novel Coronavirus-induced Pneumonia, have been suggested antiviral agents containing: Interferon alpha (IFN-α), lopinavir/ritonavir, chloroquine phosphate, ribavirin, and arbidol as potential options in COVID-19 treatment.
 <xref rid="bib0025" ref-type="bibr">
  <sup>25</sup>
 </xref> Drugs that have been considered in COVID-19 management have been classified as investigational drugs, drugs under clinical trials, and drugs that have received U.S. Food and Drug Administration (FDA) as shown in 
 <xref rid="tbl0002" ref-type="table">Table 2</xref> .
</p>
